The ratings assignment is based on a number of factors, including CHLA’s strong brand name and reputation for clinical and research excellence.
The outlook is stable, reflecting Moody’s Investors Service’s expectation CHLA’s cash flow will grow during the next several years as the organization implements its performance improvement plans.
More articles on healthcare finance:
Moody’s assigns ‘Baa2’ rating to Eisenhower Medical Center’s bonds
Moody’s affirms ‘Baa2’ rating on Exeter Hospital’s bonds
Moody’s affirms ‘A2′ rating on University Hospitals’ bonds
